FDA approves first-line treatment for peripheral T-cell lymphoma under new review pilot - FDA Press Releases

The FDA expanded the approved use of Adcetris (brentuximab vedotin) injection in combination with chemotherapy for adult patients with certain types of peripheral T-cell lymphoma (PTCL). This is the first FDA approval for treatment of newly diagnosed PTCL, and the agency used a new review program to complete the approval more quickly.

from Food and Drug Administration--Press Releases https://ift.tt/2RS1xHC
via IFTTT